Chen, Yu-Wei <br/><br/>
Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.  [electronic resource] 

 -  PloS one  2017 
 - e0171753 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0171753  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Adult<br/>Aged<br/>Biomarkers, Pharmacological--blood<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--blood<br/>Dipeptides--therapeutic use<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Female<br/>Glycated Hemoglobin--analysis<br/>Health Status Indicators<br/>Humans<br/>Linagliptin--therapeutic use<br/>Male<br/>Middle Aged<br/>Nitriles--therapeutic use<br/>Predictive Value of Tests<br/>Prognosis<br/>Pyrrolidines--therapeutic use<br/>Retrospective Studies<br/>Sitagliptin Phosphate--therapeutic use<br/>Treatment Outcome<br/>Vildagliptin